Search clinical trials for: esenciální hypertenze

Total 11390 results

Seoul National University Bundang Hospital
Hanlim Pharm. Co., Ltd.

Unknown

S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension

Essential Hypertension

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

Fimasartan Achieving SBP Target (FAST) Study (FAST)

Essential,Hypertension

Korea, Republic of
Beata Krasinska

Completed

Antiplatlet Effects of Standardized Tomato Extract in Hypertensive Subjects

Obesity | Hypertension,Essential
Proteus Digital Health, Inc.

Completed

Helius in Hypertension-I: The UK Hypertension Registry

Essential Hypertension
Poznan University of Medical Sciences

Completed

Reduction of Left Ventricular Hypertrophy After Eplerenone Therapy

Obstructive Sleep Apnea | Left Ventricular Hypertrophy | Hypertension,Essential
Takeda

Withdrawn

An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential Hypertension

Hypertension

China
Bayer

Withdrawn

Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination in Subjects With Essential Hypertension Inadequately Controlled on Candesartan Cilexetil

Hypertension

Italy
Novartis

Completed

Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension.

Hypertension

Germany, United States
First Affiliated Hospital, Sun Yat-Sen University

Unknown

Effect of Aerobic EXercise on MiCroVAscular RarefacTION in Chinese Mild HyperteNsive Patients（EXCAVATION-CHN1）

Primary Hypertension

China
Bayer

Completed

Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension (DISTINCT)

Hypertension, Essential

Spain, Argentina, United States, Canada, Korea, Republic of, Italy, Russian Federation, South Africa, Ukraine, Belgium, Brazil, Lithuania, United Kingdom
Dong-A ST Co., Ltd.

Completed

The Efficacy and Safety of OROSARTAN® Versus CODIOVAN® in Patients With Essential Hypertension Uncontrolled With Monotherapy

Hypertension

Korea, Republic of
Novartis

Completed

Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)

Hypertension

Japan
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of CVAA489 in Hypertensive Patients

Essential Hypertension

Turkey
Kyoto University
University of the Ryukyus

Completed

Diuretics In the Management of Essential Hypertension (DIME) Study

Hypertension

Japan
Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., China

Completed

A Randomized Controlled Study to Assess the Effects of Bisoprolol and Atenolol on Resting Heart Rate and Sympathetic Nervous System's Activity in Subjects With Essential Hypertension

Hypertension

China
Chong Kun Dang Pharmaceutical

Unknown

Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure (DELIGHT)

Essential Hypertension | Congestive Heart Failure | Chronic Stable Angina
Novartis

Completed

A Study of VAH631 in Patients With Essential Hypertension (Factorial Study)

Hypertension

Japan
Novartis Pharmaceuticals

Completed

Long Term Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension

Essential Hypertension

Japan
Novartis

Completed

Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension.

Essential Hypertension

Switzerland, Germany
Novartis

Completed

A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by Monotherapy

Primary Hypertension

Egypt
Boryung Pharmaceutical Co., Ltd

Completed

A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Rosuvastatin in Comparison to Each Component Administered Alone in Patients With Essential Hypertension and Dyslipidemia

Essential Hypertension, Dyslipidemia

Korea, Republic of
EMS

Withdrawn

Efficacy and Safety of Candesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control

Essential Arterial Hypertension
EMS

Withdrawn

Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension Control

Essential Arterial Hypertension
Daewoong Pharmaceutical Co. LTD.

Unknown

Observational Study to Investigate the Effectiveness and Safety of Olostar Tab in Patients With Essential Hypertension and Dyslipidemia

Hypertension | Dyslipidemias

Korea, Republic of
Novartis Pharmaceuticals

Completed

Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Asian Patients With Essential Hypertension

Essential Hypertension

China, Korea, Republic of, Taiwan, Hong Kong, Thailand, Philippines, Singapore
GlaxoSmithKline

Completed

Research Study To Test Carvedilol CR + Lisinopril Versus Lisinopril + Placebo In Patients With High Blood Pressure

Hypertension

United States
Kurume University

Unknown

Efficacy of Olmesartan on Cerebral Glucose Metabolism, Vascular Inflammation and Adipose Tissue

Efficacy of Olmesartan on Cerebral Glucose Metabolism in Essential Hypertension

Japan
IlDong Pharmaceutical Co Ltd

Completed

Efficacy and Safety of TAH Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension Patients

Essential Hypertension

Korea, Republic of
Shin Poong Pharmaceutical Co. Ltd.

Completed

Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension

Essential Hypertension

Korea, Republic of
Novartis

Completed

Study Comparing SPP100 (Aliskiren) 150mg to Placebo and to Losartan 50mg in Patients With Mild to Moderate Essential Hypertension

Hypertension

Japan
Assistance Publique - Hôpitaux de Paris

Completed

Study of Myocardial Interstitial Fibrosis in Hyperaldosteronism (COEURALDO)

Healthy | Essential Hypertension | Primary Hyperaldosteronism | Secondary Hyperaldosteronism

France
Tokyo University

Completed

Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine (ONEAST)

Essential Hypertension

Japan
Hanmi Pharmaceutical Company Limited

Completed

Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential Hypertension

Hypertension

Korea, Republic of
Quantum Genomics SA

Completed

Phase IIa Study of the Product QGC001 Compared With Placebo in Patients With Essential Hypertension (2QG1)

Essential Hypertension

France
Aarhus University Hospital Skejby
Aarhus University Hospital; Regional Hospital Holstebro; Regionshospitalet Silkeborg and other collaborators

Completed

Renal Sympathectomy in Treatment Resistant Essential Hypertension, a Sham Controlled Randomized Trial (ReSET)

Hypertension

Denmark
Shanghai AngioCare Medical

Unknown

Renal Denervation by Iberis MultiElectrode Renal Denervation System in Patients With Primary Hypertension (Iberis-HTN)

Primary Hypertension
Khon Kaen University

Completed

Non-pharmacological Treatment for Essential Isolated Systolic Hypertension in Elderly

Systolic Essential Hypertension

Thailand
China Academy of Chinese Medical Sciences
Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Completed

Causal Inference Research of Resistant Hypertension Treatment With Chinese Approach in a Cohort Study

Hypertension, Resistant to Conventional Therapy | Primary Hypertension

China
Egalet Ltd

Terminated

A Study of Controlled-Release Carvedilol Compared to Immediate-Release Carvedilol in Patients With Primary Hypertension

Hypertension

Denmark
Boryung Pharmaceutical Co., Ltd
Asan Medical Center; Ulsan University Hospital; Korea University Anam Hospital; Dong-A University and other collaborators

Completed

A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension (fimasartan)

Hypertension

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets

Essential Hypertension

Korea, Republic of
Chengdu University of Traditional Chinese Medicine
Hunan University of Traditional Chinese Medicine

Completed

Effect of Acupuncture on Patients With Mild Hypertension (EAPMH)

Essential Hypertension

China
Takeda

Withdrawn

A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia. (ALIVE)

Essential Hypertension With Stable Angina and Dyslipidemia

Japan
University of Johannesburg

Completed

The Effect of a Homoeopathic Complex on Blood Pressure in Refractory Hypertension

Essential Hypertension

South Africa
LG Life Sciences

Unknown

Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Essential Hypertension Patients

Orthostatic Hypertension | Lower Leg Edema

Korea, Republic of
University of Pavia

Completed

Canrenone as Add-on in Patients With Essential Hypertension

Essential Hypertension
Guangdong Provincial People's Hospital

Unknown

Potential Associated Factors of Uncontrolled Hypertension

Hypertension,Essential

China
United Therapeutics

Completed

Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies (Aspire)

Pulmonary Arterial Hypertension

United States
Novartis Pharmaceuticals

Completed

Efficacy and Safety of LCZ696 Compared to Placebo in Patients With Essential Hypertension

Hypertension

China, Taiwan, Japan, Thailand, Korea, Republic of
Universidade Federal do vale do São Francisco

Completed

Essential Oil of Eucalyptus Effect on Cardiovascular Responses

Hypertension

3

Subscribe